5023 Stories, most recent news story added Thu Dec 10, 3:50 pm ET
THURSDAY, Dec. 10 (HealthDay News) -- An additive that allows for more efficient storage of blood platelets up to five days has been approved by the U.S. Food and Drug Administration.
The treatment for Gaucher disease has been granted orphan-drug designation and fast-track status by the FDA to facilitate its development.
Nearly $100 million in spending earmarked by Maryland lawmakers appears headed to more than 70 projects in the state under a huge year-end spending measure that the House approved Thursday.
PHILADELPHIA----Lannett Company, Inc. today announced that it has received approvals from the U.S. Food and Drug Administration of its Abbreviated New Drug Applications for Hydromorphone Hydrochloride Tablets USP, 2 mg, 4 mg and 8 mg, the generic equivalent of Purdue Pharmaceuticals’ Dilaudid® Tablets 2 mg, 4 mg and 8 mg.
WASHINGTON, Dec. 10 (UPI) -- The U.S. Food and Drug Administration has issued a warning about rare, but serious, complications from the use of negative pressure wound therapy devices.
-
SAN ANTONIO----Azaya Therapeutics, Inc. announced today that the Food and Drug Administration has approved its Investigational New Drug application for its lead product “ATI-1123,” a novel and improved formulation of Taxotere® , a leading chemotherapy drug with worldwide annual sales of over $2.8 billion.
CAMBRIDGE, Mass., Dec. 10 /PRNewswire/ -- Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that the U.S.
SILVER SPRING, Md., Dec. 10 /PRNewswire-USNewswire/ -- The U.S.
Landau Building Co. completed the West Virginia University Hospitals new 40,000-square-foot Commercial Laundry Facility in Morgantown Industrial Park, Morgantown, W.Va.
State officials approved a $250,000 forgivable loan Thursday for a Lexington biosciences firm.From
Amgen Inc. (AMGN) said tests of its bone drug denosumab showed it reduced the risk of developing multiple skeletal related events by 23% compared with Novartis AG's (NVS) Zometa in patients with advanced breast cancer.
SILVER SPRING, Md., Dec. 10 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) has notified health professionals, and advised patients, about rare but serious complications -- including deaths -- from the use of negative pressure wound therapy (NPWT).
Cequent Pharmaceuticals announced this week that its new drug application for an oral RNAi-based treatment for advanced familial adenomatous polyposis has been approved by the US Food and Drug Administration.
WASHINGTON, Dec. 10 (UPI) -- The U.S. Food and Drug Administration says it has approved the first solution to replace a portion of plasma used when storing blood platelets.
GORDONSVILLE, VA--(Marketwire - December 10, 2009) - On October 1, changes were made to the federal WIC program that provides nutritional support to low-income women, infants and children. The goal of the new food package is to encourage breastfeeding because mother's milk is best for babies. Mothers who breastfeed will no longer receive any infant formula under the new program. Mothers who ...
